Mapatumumab Human Monoclonal Antibody
Mapatumumabis a research-grade recombinant antibody targeting CD261. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
TNF-related apoptosis-inducing ligand receptor 1, APO2, Death receptor 4, TRAIL receptor 1, TRAIL-R1, CD261, DR4, TRAILR1, TNFRSF10A, Tumor necrosis factor receptor superfamily member 10A
UniProt
O00220
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-nd
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8103999-01 0.02 mL
Recombinant Anti-CD21 Antibody, Rabbit Monoclonal
Sign In for Pricing
View Details MBS8103999-02 0.1 mL
Recombinant Anti-CD21 Antibody, Rabbit Monoclonal
Sign In for Pricing
View Details MBS8103999-03 5x 0.1 mL
Recombinant Anti-CD21 Antibody, Rabbit Monoclonal
Sign In for Pricing
View Details